
Christopher R. Stone
Examiner (ID: 10415, Phone: (571)270-3494 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1609, 1614, 1628, 4173 |
| Total Applications | 750 |
| Issued Applications | 250 |
| Pending Applications | 42 |
| Abandoned Applications | 457 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5558805
[patent_doc_number] => 20090270382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'Soluble epoxide hydrolase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/426136
[patent_app_country] => US
[patent_app_date] => 2009-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17831
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20090270382.pdf
[firstpage_image] =>[orig_patent_app_number] => 12426136
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/426136 | Soluble epoxide hydrolase inhibitors | Apr 16, 2009 | Abandoned |
Array
(
[id] => 5404764
[patent_doc_number] => 20090240079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases'
[patent_app_type] => utility
[patent_app_number] => 12/421442
[patent_app_country] => US
[patent_app_date] => 2009-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 11417
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20090240079.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421442
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421442 | Pharmaceutical Composition for Treating or Preventing Degenerative and Inflammatory Diseases | Apr 8, 2009 | Abandoned |
Array
(
[id] => 5474433
[patent_doc_number] => 20090247599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'METHODS OF TREATING CELL PROLIFERATIVE DISORDERS USING A COMPRESSED TEMOZOLOMIDE DOSING SCHEDULE'
[patent_app_type] => utility
[patent_app_number] => 12/420109
[patent_app_country] => US
[patent_app_date] => 2009-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8222
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247599.pdf
[firstpage_image] =>[orig_patent_app_number] => 12420109
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/420109 | METHODS OF TREATING CELL PROLIFERATIVE DISORDERS USING A COMPRESSED TEMOZOLOMIDE DOSING SCHEDULE | Apr 7, 2009 | Abandoned |
Array
(
[id] => 10089005
[patent_doc_number] => 09125809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Pectin-containing jelly formulation'
[patent_app_type] => utility
[patent_app_number] => 13/262800
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 5562
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262800
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262800 | Pectin-containing jelly formulation | Apr 2, 2009 | Issued |
Array
(
[id] => 5474328
[patent_doc_number] => 20090247494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Omega-3 essential fatty acid composition and method for treatment of anal and colon-rectal disorders'
[patent_app_type] => utility
[patent_app_number] => 12/414414
[patent_app_country] => US
[patent_app_date] => 2009-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 649
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247494.pdf
[firstpage_image] =>[orig_patent_app_number] => 12414414
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/414414 | Omega-3 essential fatty acid composition and method for treatment of anal and colon-rectal disorders | Mar 29, 2009 | Abandoned |
Array
(
[id] => 5404587
[patent_doc_number] => 20090239901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'METHOD AND COMPOSITIONS FOR TREATMENT OF CEREBRAL MALARIA'
[patent_app_type] => utility
[patent_app_number] => 12/407010
[patent_app_country] => US
[patent_app_date] => 2009-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 1881
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239901.pdf
[firstpage_image] =>[orig_patent_app_number] => 12407010
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/407010 | METHOD AND COMPOSITIONS FOR TREATMENT OF CEREBRAL MALARIA | Mar 18, 2009 | Abandoned |
Array
(
[id] => 6136683
[patent_doc_number] => 20110009404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => '4-ARYL-2-ANILINO-PYRIMIDINES'
[patent_app_type] => utility
[patent_app_number] => 12/921499
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35973
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009404.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921499
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921499 | 4-aryl-2-anilino-pyrimidines | Mar 8, 2009 | Issued |
Array
(
[id] => 7501603
[patent_doc_number] => 20110263546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'Polyhydroxylated Bile Acids for Treatment of Biliary Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/919381
[patent_app_country] => US
[patent_app_date] => 2009-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16225
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20110263546.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919381
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919381 | Polyhydroxylated Bile Acids for Treatment of Biliary Disorders | Feb 25, 2009 | Abandoned |
Array
(
[id] => 5576091
[patent_doc_number] => 20090143453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES'
[patent_app_type] => utility
[patent_app_number] => 12/366968
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12185
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143453.pdf
[firstpage_image] =>[orig_patent_app_number] => 12366968
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/366968 | METHODS FOR TREATING DEGENERATIVE DISEASES/INJURIES | Feb 5, 2009 | Abandoned |
Array
(
[id] => 5480752
[patent_doc_number] => 20090203709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/365966
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8867
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203709.pdf
[firstpage_image] =>[orig_patent_app_number] => 12365966
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/365966 | Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor | Feb 4, 2009 | Abandoned |
Array
(
[id] => 9059935
[patent_doc_number] => 08546370
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Compounds and compositions as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/865339
[patent_app_country] => US
[patent_app_date] => 2009-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81891
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12865339
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865339 | Compounds and compositions as kinase inhibitors | Jan 26, 2009 | Issued |
Array
(
[id] => 6097605
[patent_doc_number] => 20110003790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'PYRIDO [4, 3-D] PYRIMIDINONE DERIVATIVES AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/865367
[patent_app_country] => US
[patent_app_date] => 2009-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52652
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003790.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865367
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865367 | Pyrido [4, 3-D] pyrimidinone derivatives as kinase inhibitors | Jan 26, 2009 | Issued |
Array
(
[id] => 6618672
[patent_doc_number] => 20100324087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'COMBINED USE OF ANGIOGENESIS INHIBITOR AND TAXANE'
[patent_app_type] => utility
[patent_app_number] => 12/864817
[patent_app_country] => US
[patent_app_date] => 2009-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12728
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20100324087.pdf
[firstpage_image] =>[orig_patent_app_number] => 12864817
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/864817 | COMBINED USE OF ANGIOGENESIS INHIBITOR AND TAXANE | Jan 26, 2009 | Abandoned |
Array
(
[id] => 5576102
[patent_doc_number] => 20090143464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Method for preventing and/or treating peripheral Neuropathies induced by the administration of an anticancer agent'
[patent_app_type] => utility
[patent_app_number] => 12/320430
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19644
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143464.pdf
[firstpage_image] =>[orig_patent_app_number] => 12320430
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/320430 | Method for preventing and/or treating peripheral Neuropathies induced by the administration of an anticancer agent | Jan 25, 2009 | Abandoned |
Array
(
[id] => 5564766
[patent_doc_number] => 20090137619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent'
[patent_app_type] => utility
[patent_app_number] => 12/320422
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19646
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20090137619.pdf
[firstpage_image] =>[orig_patent_app_number] => 12320422
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/320422 | Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent | Jan 25, 2009 | Abandoned |
Array
(
[id] => 5398414
[patent_doc_number] => 20090318477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'CHEMICAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/373524
[patent_app_country] => US
[patent_app_date] => 2007-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 76885
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318477.pdf
[firstpage_image] =>[orig_patent_app_number] => 12373524
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/373524 | Chemical compounds | Jan 12, 2009 | Issued |
Array
(
[id] => 5489995
[patent_doc_number] => 20090291066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => ' COMPOSITION AND METHOD OF TREATING FACIAL SKIN DEFECT'
[patent_app_type] => utility
[patent_app_number] => 12/351942
[patent_app_country] => US
[patent_app_date] => 2009-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6314
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291066.pdf
[firstpage_image] =>[orig_patent_app_number] => 12351942
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/351942 | COMPOSITION AND METHOD OF TREATING FACIAL SKIN DEFECT | Jan 11, 2009 | Abandoned |
Array
(
[id] => 6561391
[patent_doc_number] => 20100272711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/747147
[patent_app_country] => US
[patent_app_date] => 2008-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 39706
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20100272711.pdf
[firstpage_image] =>[orig_patent_app_number] => 12747147
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747147 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES | Dec 11, 2008 | Abandoned |
Array
(
[id] => 8875797
[patent_doc_number] => 08470763
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-25
[patent_title] => 'Alpha-amino-N-substituted amides, pharmaceutical composition containing them and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/747485
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 14600
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12747485
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/747485 | Alpha-amino-N-substituted amides, pharmaceutical composition containing them and uses thereof | Dec 10, 2008 | Issued |
Array
(
[id] => 6249527
[patent_doc_number] => 20100137449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'SUBSTITUTED 1,3-CYCLOPENTADIONE MULTI-TARGET PROTEIN KINASE MODULATORS OF CANCER, ANGIOGENESIS AND THE INFLAMMATORY PATHWAYS ASSOCIATED THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 12/331887
[patent_app_country] => US
[patent_app_date] => 2008-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 27440
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137449.pdf
[firstpage_image] =>[orig_patent_app_number] => 12331887
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/331887 | SUBSTITUTED 1,3-CYCLOPENTADIONE MULTI-TARGET PROTEIN KINASE MODULATORS OF CANCER, ANGIOGENESIS AND THE INFLAMMATORY PATHWAYS ASSOCIATED THEREWITH | Dec 9, 2008 | Abandoned |